Intervention Review

Trazodone for agitation in dementia

  1. Georgina Martinón-Torres2,
  2. Mario Fioravanti3,
  3. John Grimley Evans1,*

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 19 JUL 2004

Assessed as up-to-date: 10 APR 2008

DOI: 10.1002/14651858.CD004990


How to Cite

Martinón-Torres G, Fioravanti M, Grimley Evans J. Trazodone for agitation in dementia. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004990. DOI: 10.1002/14651858.CD004990.

Author Information

  1. 1

    University of Oxford, Division of Clinical Geratology, Nuffield Department of Clinical Medicine, Oxford, UK

  2. 2

    Complejo Hospitalario de Ciudad Real, Ciudad Real, Spain

  3. 3

    University of Rome "La Sapienza", Department of Psychiatric Science and Psychological Medicine, Rome, Italy

*John Grimley Evans, Division of Clinical Geratology, Nuffield Department of Clinical Medicine, University of Oxford, Radcliffe Infirmary, Woodstock Road, Oxford, OX2 6HE, UK. john.grimleyevans@green.ox.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 19 JUL 2004

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Delia Bishara, David Taylor, Robert J. Howard, Rauja Abdel-Tawab, Expert opinion on the management of behavioural and psychological symptoms of dementia (BPSD) and investigation into prescribing practices in the UK, International Journal of Geriatric Psychiatry, 2009, 24, 9
  2. 2
    Jean-François Locca, Christophe J. Büla, Serge Zumbach, Oliver Bugnon, Pharmacological Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD) in Nursing Homes: Development of Practice Recommendations in a Swiss Canton, Journal of the American Medical Directors Association, 2008, 9, 6, 439

    CrossRef

  3. 3
    Secundino López-Pousa, Josep Garre-Olmo, Joan Vilalta-Franch, Antoni Turon-Estrada, Imma Pericot-Nierga, Trazodone for Alzheimer's disease: A naturalistic follow-up study, Archives of Gerontology and Geriatrics, 2008, 47, 2, 207

    CrossRef

  4. 4
    Lola Roldán-Tapia, Rosa Cánovas-López, José Cimadevilla, Matías Valverde, Déficit mnésicos y perceptivos en la fibromialgia y la artritis reumatoide, Reumatología Clínica, 2007, 3, 3, 101

    CrossRef

  5. 5
    Dallas P Seitz, Nikesh Adunuri, Sudeep Gill, Andrea Gruneir, Nathan Herrmann, Paula Rochon, Antidepressants for agitation and psychosis in dementia, The Cochrane Library,
  6. 6
    Dallas P Seitz, Nikesh Adunuri, Sudeep S. Gill, Andrea Gruneir, Nathan Herrmann, Paula Rochon, Antidepressants for agitation and psychosis in dementia, The Cochrane Library,
  7. 7
    Bart M. Demaerschalk, Bryan K. Woodruff, Richard J. Caselli, Dementia Treatment: Let the Evidence Lead us,
  8. 8
    Georgina Martinón-Torres, Mario Fioravanti, John Grimley Evans, Trazodone for agitation in dementia, The Cochrane Library,